Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|March 28, 2007
Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and IsraelKimberley Clawson Stone, Ron Dagan, Adriano Arguedas, et al.Antimicrobial Agents and Chemotherapy|May 23, 2003
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United StatesJames A Karlowsky, Clyde Thornsberry, Ian A Critchley, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2002
Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000Clyde Thornsberry, Daniel F Sahm, Laurie J Kelly, et al.International Journal of Antimicrobial Agents|January 30, 2002
Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance NetworkJames A Karlowsky, Laurie J Kelly, Clyde Thornsberry, et al.International Journal of Antimicrobial Agents|September 26, 2002
Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000Ian A Critchley, Renée S Blosser-Middleton, Mark E Jones, et al.Journal of Clinical Microbiology|March 7, 2002
Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strainJames A Karlowsky, Ian A Critchley, Renée S Blosser-Middleton, et al.Journal of Clinical Microbiology|March 23, 2018
Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosaHelio S Sader, Paul R Rhomberg, Michael D Huband, et al.Antimicrobial Agents and Chemotherapy|May 23, 2002
In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IVMark E Jones, Ian A Critchley, James A Karlowsky, et al.Antimicrobial Agents and Chemotherapy|January 24, 2019
Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial PneumoniaShampa Das, Jianguo Li, Todd Riccobene, et al.Chemotherapy|December 12, 2002
The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000Mark E Jones, Renee S Blosser-Middleton, Ian A Critchley, et al.Pageof 6